Influence of maximal vasodilatation on glucose and sodium blood-tissue transport in canine heart.
D000818:Animals; D001693:Biological Transport, Active; D001794:Blood Pressure / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects*; D002860:Chromium Radioisotopes; D003331:Coronary Vessels / Q000187:drug effects*; D004058:Diffusion; D004176:Dipyridamole / Q000494:pharmacology; D004285:Dogs; D005947:Glucose / Q000378:metabolism*; D006400:Hematocrit; D008833:Microcirculation; D009206:Myocardium / Q000378:metabolism; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010477:Perfusion; D011868:Radioisotopes; D012964:Sodium / Q000378:metabolism*; D012975:Sodium Isotopes; D014316:Tritium; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D002860:Chromium Radioisotopes; D011868:Radioisotopes; D012975:Sodium Isotopes; D014665:Vasodilator Agents; D014316:Tritium; D004176:Dipyridamole; D012964:Sodium; D010208:Papaverine; D005996:Nitroglycerin; D005947:Glucose; D009638:Norepinephrine